Frost Mark T bought HBIO
March 16, 2026 · Form 4 insider transaction
Frost Mark T bought 5,000 shares of Harvard Bioscience, Inc. at $5.00 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 16 days after the transaction.
Footnotes
Includes (a) 5,000 shares of common stock purchased on March 16, 2026, (b) 10,000 restricted stock units that will vest on May 12, 2026, and (c) 2,500 shares of common stock beneficially owned by the Reporting Person.; On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1. The 10,000 restricted stock units referenced in Footnote 1(b) were previously reported as covering 100,000 restricted stock units and the 2,500 shares of common stock referenced in Footnote 1(c) were previously reported as covering 25,000 shares of common stock. These numbers have been adjusted to reflect the stock split that occurred on March 13, 2026.